HCM
EDIT icon

Hollencrest Capital Management’s Editas Medicine EDIT Stock Holding History

Hollencrest Capital Management’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.3K Hold
400
– – ﹤0.01% 1064
2026
Q1 		$988 Hold
400
– – ﹤0.01% 1088
2025
Q4 		$820 Sell
400
-100
-20% -$289 ﹤0.01% 1081
2025
Q3 		$1.74K Hold
500
– – ﹤0.01% 1005
2025
Q2 		$1.1K Hold
500
– – ﹤0.01% 1013
2025
Q1 		$580 Hold
500
– – ﹤0.01% 1049
2024
Q4 		$635 Hold
500
– – ﹤0.01% 1096
2024
Q3 		$1.71K Sell
500
-115
-19% -$501 ﹤0.01% 973
2024
Q2 		$2.87K Hold
615
– – ﹤0.01% 895
2024
Q1 		$4.56K Hold
615
– – ﹤0.01% 826
2023
Q4 		$6.23K Hold
615
– – ﹤0.01% 778
2023
Q3 		$4.8K Hold
615
– – ﹤0.01% 825
2023
Q2 		$5.06K Hold
615
– – ﹤0.01% 848
2023
Q1 		$4.46K Hold
615
– – ﹤0.01% 864
2022
Q4 		$5.46K Buy
+615
New +$6.75K ﹤0.01% 812

Other funds holding EDIT

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Hollencrest Capital Management's EDIT Position: Q2 2026 in Review

Hollencrest Capital Management held its Editas Medicine (EDIT) position steady in Q2 2026 at 400 shares worth $1.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1064.

Hollencrest Capital Management first reported a position in EDIT in Q4 2022 and has held it in 15 quarters since. The position peaked at $6.23K in Q4 2023. 214 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • Hollencrest Capital Management held 400 shares of Editas Medicine worth $1.3K as of Q2 2026.
  • Hollencrest Capital Management left its Editas Medicine share count unchanged in Q2 2026.
  • Editas Medicine made up ﹤0.01% of Hollencrest Capital Management's portfolio in Q2 2026, its #1064 holding.
  • Hollencrest Capital Management first reported a position in Editas Medicine in Q4 2022 and has held it in 15 quarters since.
  • Hollencrest Capital Management's Editas Medicine position peaked at $6.23K in Q4 2023.
  • 214 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Hollencrest Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.